{
  "title": "ADVN Biomarker Registry: Neutrophil Substudy",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY9",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "ADVN Biomarker Registry: Neutrophil Substudy",
  "performedBy": [
    {
      "firstName": "Donald",
      "lastName": "Leung",
      "email": "leungd@njhealth.org",
      "affiliations": [
          {
             "name": "National Jewish Health"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Richard",
      "lastName": "Gallo",
      "email": "RGallo@ucsd.edu",
      "affiliations": [
          {
             "name": "University of California at San Diego"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Lisa",
      "lastName": "Beck",
      "email": "Lisa_Beck@URMC.ROCHESTER.EDU",
      "affiliations": [
          {
             "name": "University of Rochester Medical Center"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "AD+ EH+",
          "size": 20
        },
        {
          "name": "AD+ EH-",
          "size": 20
        },
        {
          "name": "Healthy controls",
          "size": 21
        }
  ],
  
  "usesReagent": [
        {
          "name": "IL17"
        },
        {
          "name": "Abcam MAb for alpha subunit of the CD11b/CD18 (Mac-1) complex"
        },
        {
          "name": "CD16-PE"
        },
        {
          "name": "7AAD-PE-Cy5"
        },
        {
          "name": "CD11a-APC"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Sign the informed consent form (or a parent or guardian, if applicable)."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "8 months to 80 years of age."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Residing in the U.S."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "No systemic disorders (i.e., immunodeficiency disorders such as human immunodeficiency virus [HIV] or lupus erythematosus) other than the condition being studied."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Meet the criteria for one of the diagnostic groups (ADEH+, ADEH-, or NA; see Appendix I), as confirmed by an ADVN investigator or co-investigator.  The standardized definitions (see Appendix I) for ADEH+, ADEH-, and NA Control have been developed for use in all ADVN studies and will be used to determine eligibility."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Subjects must be enrolled in the ADVN Biomarker Registry Study prior to the Neutrophil Substudy."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Unable or unwilling to complete the informed consent process."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Has atopy but lacks stringent AD features (only presumptive diagnosis of AD)."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "History of any systemic illness other than the condition being studied."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Has autoimmune or immunodeficiency disease.  Presence of active systemic malignancy, excluding uncomplicated non-melanoma skin cancer. "
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Presence of any skin disease other than AD that might compromise the stratum corneum barrier (e.g., bullous disease, psoriasis, cutaneous T cell lymphoma [also called Mycosis Fungoides or Sezary syndrome])."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Receiving an experimental new drug as part of a separate clinical trial.  If it is a Food and Drug Administration (FDA) approved drug the subject will be allowed to enroll and the information will be captured in their medication history."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects receiving systemic immunosuppressives, oral corticosteroids, or immunomodulatory medicaion within 12 days of enrollment."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects receiving immunotherapy within the last year."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects using topical medications including (but not restricted to) Elidel, Protopic, topical corticosteroids, or topical antibiotics at the site of the blood draw within the last 72 hours."
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Lisa",
      "lastName": "Beck",
      "email": "Lisa_Beck@URMC.ROCHESTER.EDU",
      "affiliations": [
          {
             "name": "University of Rochester Medical Center"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Atopic Dermatitis & Vaccinia Network (ADVN) Clinical Studies Consortium",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "N01 AI040029"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "The Atopic Dermatitis and Vaccinia Network (ADVN) is a consortium of academic medical centers that will conduct clinical research studies in an attempt to make smallpox vaccines safer for millions of people with atopic dermatitis.  http://projectreporter.nih.gov/project_info_description.cfm?aid=7337882&icde=23823696&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Clinical Trial"
      },
      {
        "value": "Observational"
      },
      {
        "value": "Atopy/Allergy"
      }
  ],
  "dates": [
      {
          "date": "2008-07-08",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2009-02-28",
          "type": {
              "value": "actual_completion_date"
          }
      },
      {
          "date": "2012-11-16",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "The upregulation of CD11b on neutrophils is determined by the change(Net and Fold) in MFI (Median, Mean, and Geometric Mean are evaluated) from the baseline expression of CD11b to the increasing concentrations of the chemoattractant CXCL8 (IL-8). Two multichromaticpanels are used for the evaluation with both containing CD11b. CD11b from Abcam recognizes the alpha subunit of the CD11b/CD18 (Mac-1) complex. The CD11b from eBioscience reacts with anactivation specific epitope of this same integrin complex.",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      },{
        "name": {
            "value": "Physical Exam"
        }
      },{
        "name": {
            "value": "Medical History"
        }
      },{
        "name": {
            "value": "Interim Skin Infection History"
        }
      },{
        "name": {
            "value": "Interim Medical History"
        }
      },{
        "name": {
            "value": "Family History"
        }
      },{
        "name": {
            "value": "EASI Score"
        }
      },{
        "name": {
            "value": "Any medications taken?"
        }
      },{
        "name": {
            "value": "Any Adverse Event?"
        }
      },{
        "name": {
            "value": "Vaccination and Viral History"
        }
      },{
        "name": {
            "value": "Skin/Integument exam"
        }
      },{
        "name": {
            "value": "Skin Infection History"
        }
      },{
        "name": {
            "value": "Rajka-Langeland Score Assessment"
        }
      }
      
  ],
  "isAbout": [
        {
          "name": "IL-8 1000"
        },
        {
          "name": "IL-8 100"
        },
        {
          "name": "IL-8 10"
        },
        {
          "name": "IL-8 1"
        },
        {
          "name": "IL-8 0"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY9",
              "identifierSource": "ImmPort"
          },
          "title": "ADVN Biomarker Registry: Neutrophil Substudy",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY9",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Atopic Dermatitis & Vaccinia Network (ADVN) Clinical Studies Consortium",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=6358320&icde=23811074&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "To evaluate the chemotactic function of peripheral blood leukocytes such as neutrophils in subjects with ADEH+, ADEH-, and NA controls."
}
